HB3480, titled the Health Coverage for IVF Act of 2025, would amend the Affordable Care Act to make fertility treatment and care an essential health benefit. The bill defines fertility treatment and care broadly to include fertility preservation, artificial insemination, assisted reproductive technology such as in vitro fertilization, embryo genetic testing, fertility medications, gamete donation, and other related services the Secretary of Health and Human Services determines appropriate. It also specifies that covered services should include at least three complete oocyte retrievals and an unlimited number of embryo transfers from those retrievals, subject to clinical appropriateness and professional guidelines.
The bill further adds new federal requirements for individual and small-group market plans that cover fertility services. Those plans could not impose more restrictive cost-sharing or treatment limits on fertility care than they apply to substantially all other medical and surgical benefits, and insurers could not deny fertility benefits solely because a person lacks an infertility diagnosis. The bill also requires insurers using utilization management tools for fertility care to analyze and report how those tools are applied, and directs the Comptroller General to summarize those reports and identify compliance issues. The amendments would take effect for plan years beginning one year after enactment.
Impact
If enacted, HB3480 would expand federal health insurance standards under the Affordable Care Act and the Public Health Service Act by explicitly adding fertility treatment and care to the list of essential health benefits and by imposing parity-style protections in the individual and small-group markets. It would affect health insurers, plan administrators, and consumers by requiring broader coverage, limiting discriminatory cost-sharing and treatment restrictions, and increasing reporting and oversight obligations related to utilization management. The bill would also create a new federal baseline for fertility-related coverage that could influence state-regulated insurance markets and employer-sponsored plan design where applicable.
Sentiment
Based on the bill text and available context, the overall sentiment appears supportive of expanding access to fertility care and IVF coverage. The measure’s title and structure indicate a pro-coverage approach aimed at making fertility services more accessible and less restricted by insurance barriers. No committee transcript or vote record is available in the provided materials, so there is no recorded opposition or amendment debate to assess from the legislative history here.
Contention
The main policy tensions likely involve cost, scope, and regulatory burden. Potential critics may object to requiring coverage for a broad set of fertility services, including assisted reproductive technology, embryo genetic testing, and multiple retrievals and transfers, because of the possible premium impact on insurers and consumers. Another point of contention is the bill’s prohibition on denying fertility benefits based on the absence of an infertility diagnosis, which could be viewed as expanding coverage beyond traditional medical necessity standards. Insurers may also resist the new utilization-management reporting requirements and federal oversight by the Comptroller General.
An act to add Section 1367.73 to the Health and Safety Code, to add Section 10120.45 to the Insurance Code, and to amend Section 14132 of the Welfare and Institutions Code, relating to health care coverage.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)